Drug
statin + ezetimibe
statin + ezetimibe is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_4
1
33%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 21 (50.0%)
Phase 41 (50.0%)
Trials by Status
unknown133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_2
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
NCT07307989
recruiting
Retrospective Analysis of the Effect of In-hospital Initiation of PCSK9i on Clinical Outcomes in Chinese ACS Patients
NCT06567418
unknownphase_4
Low Dose Statins, Ezetimibe and Nutraceuticals
NCT03277079
Clinical Trials (3)
Showing 3 of 3 trials
NCT07307989Phase 2
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
NCT06567418
Retrospective Analysis of the Effect of In-hospital Initiation of PCSK9i on Clinical Outcomes in Chinese ACS Patients
NCT03277079Phase 4
Low Dose Statins, Ezetimibe and Nutraceuticals
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3